MORGAN STANLEY - STEMLINE THERAPEUTICS INC ownership

STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 74 filers reported holding STEMLINE THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 1.21 and the average weighting 0.1%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of STEMLINE THERAPEUTICS INC
ValueSharesWeighting
Q1 2020$78,000
-90.3%
16,277
-78.5%
0.00%
Q4 2019$806,000
+258.2%
75,789
+251.1%
0.00%
Q3 2019$225,000
+73.1%
21,587
+154.6%
0.00%
Q2 2019$130,000
-26.6%
8,479
-38.5%
0.00%
Q1 2019$177,000
-62.6%
13,786
-72.3%
0.00%
Q4 2018$473,000
-45.6%
49,816
-4.9%
0.00%
Q3 2018$870,000
-17.4%
52,384
-20.1%
0.00%
Q2 2018$1,053,000
+22.2%
65,573
+16.4%
0.00%
Q1 2018$862,000
+17.8%
56,348
+20.1%
0.00%
Q4 2017$732,000
+117.9%
46,908
+55.3%
0.00%
Q3 2017$336,000
+12.8%
30,213
-6.9%
0.00%
Q2 2017$298,000
-45.6%
32,448
-49.2%
0.00%
Q1 2017$548,000
-48.6%
63,916
-35.8%
0.00%
Q4 2016$1,066,000
+3130.3%
99,562
+3128.3%
0.00%
Q3 2016$33,000
+1550.0%
3,084
+1289.2%
0.00%
Q2 2016$2,0000.0%222
-57.6%
0.00%
Q1 2016$2,000
-93.5%
524
-89.4%
0.00%
Q4 2015$31,000
-83.6%
4,924
-77.0%
0.00%
Q3 2015$189,000
+15.2%
21,370
+53.7%
0.00%
Q2 2015$164,000
-0.6%
13,900
+21.8%
0.00%
Q1 2015$165,000
+5.8%
11,413
+24.8%
0.00%
Q4 2014$156,000
+105.3%
9,143
+49.7%
0.00%
Q3 2014$76,000
-18.3%
6,109
-4.5%
0.00%
Q2 2014$93,000
-92.1%
6,398
-88.9%
0.00%
Q1 2014$1,172,000
+315.6%
57,558
+299.3%
0.00%
Q4 2013$282,000
-80.3%
14,413
-54.4%
0.00%
-100.0%
Q3 2013$1,431,000
+85.6%
31,593
-2.2%
0.00%
Q2 2013$771,00032,3130.00%
Other shareholders

There were no reported owners of STEMLINE THERAPEUTICS INC in Q4 2016.

NameSharesValueWeighting ↓
View complete list of STEMLINE THERAPEUTICS INC shareholders